Prevalence and predictors of abnormal arterial function in statin-treated type 2 diabetes mellitus patients

Metabolism: Clinical and Experimental

Volumn 61, Issue 3, 2012, Pages 349-357

  Hamilton, Sandra J ^a   Chew, Gerard T ^a   Davis, Timothy M E ^a   Watts, Gerald F ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTERY DILATATION; ARTERY DISEASE; ARTERY DYSFUNCTION; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; ENDOTHELIAL DYSFUNCTION; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; FLOW MEDIATED DILATATION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NITRATE MEDIATED DILATATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; SEX; SMOOTH MUSCLE CELL DYSFUNCTION; SMOOTH MUSCLE FIBER;

ADULT; AGED; AGING; ARTERIES; BLOOD CHEMICAL ANALYSIS; BRACHIAL ARTERY; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; ODDS RATIO; PREDICTIVE VALUE OF TESTS; VASCULAR DISEASES;

EID: 84857500454     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.07.010     Document Type: Article

References (51)

1. S.M. Haffner, S. Lehto, and T. Ronnemaa Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234 (Pubitemid 28350165)
2. S.B. Williams, J.A. Cusco, and M.A. Roddy Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus JACC 27 1996 567 574 (Pubitemid 26081917)
3. M.R. Adams, J. Robinson, and R. McCredie Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis JACC 32 1998 123 127 (Pubitemid 28351052)
4. M.E. Widlansky, N. Gokce, and J. Keaney The clinical implications of endothelial dysfunction JACC 42 2003 1149 1160 (Pubitemid 37188333)
5. T.J. Anderson Prognostic significance of brachial flow-mediated vasodilation Circulation 115 2007 2373 2375 (Pubitemid 46717957)
6. J. Yeboah, J.R. Crouse, and F.C. Hsu Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study Circulation 115 2007 2390 2397 (Pubitemid 46717961)
7. V.M. Schachinger, M.B.M. Britten, and A.M.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
8. I.J. Kullo, A.R. Malik, and L.F. Bielak Brachial artery diameter and vasodilator response to nitroglycerine, but not flow-mediated dilatation, are associated with the presence and quantity of coronary artery calcium in asymptomatic adults Clin Sci 112 2007 175 182
9. R. Rawlings, A. Nohria, and P.Y. Liu Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in Caucasian men with a previous atherosclerotic event Am J Cardiol 103 2009 437 441
10. K.C.B. Tan, W.S. Chow, and S.C.F. Tam Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus J Clin Endocrinol Metab 87 2002 563 568 (Pubitemid 34158219)
11. J.C. Fruchart, F. Sacks, and M.P. Hermans The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia Am J Cardiol 102 2008 1K 34K
12. R. Collins, J. Armitage, and S. Parish MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
13. P.H. Colhoun, P.D.J. Betteridge, and P.P. Durrington Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 364 2004 685 696
14. J. Shepherd, P. Barter, and R. Carmena Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study Diabetes Care 29 2006 1220 1226 (Pubitemid 44125913)
15. American Diabetes Association Standards of medical care in diabetes-2010 Diabetes Care 33 Suppl 1 2010 S11 S61
16. 10 improves endothelial dysfunction in statin-treated type 2 diabetic patients Diabetes Care 32 2009 810 812
17. S.J. Hamilton, G.T. Chew, and T.M.E. Davis Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated type 2 diabetic patients Clin.Sci 118 2010 607 615
18. S.J. Hamilton, G.T. Chew, and T.M. Davis Niacin improves small artery vasodilatory function and compliance in statin-treated type 2 diabetic patients Diab Vasc Dis Res 7 2010 296 299
19. M.C. Corretti, T.J. Anderson, and E.J. Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force JACC 39 2002 257 265 (Pubitemid 34084631)
20. R.J. Woodman, D.A. Playford, and G.F. Watts Improved analysis of brachial artery ultrasound using a novel edge-detection software system J Appl Physiol 91 2001 929 937 (Pubitemid 32681129)
21. G.F. Watts, D.A. Playford, and K.D. Croft Coenzyme Q10 improves endothelial dysfunction of the brachial artery in type II diabetes mellitus Diabetologia 45 2002 420 426 (Pubitemid 34267365)
22. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
23. T.C. Weng, Y.H.K. Yang, and S.J. Lin A systematic review and meta-analysis on the therapeutic equivalence of statins J Clin Pharm Ther 35 2010 139 151
24. P.H. Jones, M.H. Davidson, and E.A. Stein Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial) Am J Cardiol 92 2003 152 160 (Pubitemid 36835963)
25. D. Versari, E. Daghini, and A. Virdis Endothelium-dependent contractions and endothelial dysfunction in human hypertension Brit J Pharmacol 157 2009 527 536
26. M. Preik, M. Kelm, and P. Rosen Additive effect of coexistent type 2 diabetes and arterial hypertension on endothelial dysfunction in resistance arteries of human forearm vasculature Angiology 51 2000 545 554 (Pubitemid 30482454)
27. Chronic Kidney Disease Prognosis Consortium Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
28. P. Drury, R. Ting, and D. Zannino Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study Diabetologia 54 2011 32 43
29. G. Dogra, A. Irish, and D. Chan Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD Am J Kidney Dis 48 2006 926 934 (Pubitemid 44895366)
30. G. Dogra, A. Irish, and D. Chan A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD Am J Kidney Dis 49 2007 776 785 (Pubitemid 46802930)
31. D.T. Chan, G.F. Watts, and A.B. Irish Rosiglitazone does not improve vascular function in subjects with chronic kidney disease Nephrol Dial Transplant 2011 [in press: published online March 4 2011]
32. F. Stam, C. van Guldener, and A. Becker Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study J Am Soc Nephrol 17 2006 537 545
33. V. Persy, and P. D'Haese Vascular calcification and bone disease: the calcification paradox Trends in Molecular Medicine 15 2009 405 416
34. G.I. Papaioannou, R.L. Seip, and N.J. Grey Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-Brachial Artery Reactivity study) Am J Cardiol 94 2004 294 299 (Pubitemid 38962692)
35. A.C. Keech, S.M. Grieve, and A. Patel Urinary albumin levels in the normal range determine arterial wall thickness in adults with type 2 diabetes: a FIELD substudy Diabet Med 22 2005 1558 1565 (Pubitemid 41641164)
36. M.C. Thomas, A.J. Weekes, and O.J. Broadley The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study) M JA 185 2006 140 144 (Pubitemid 44262796)
37. B.M.M. Wall, R.M. Hardison, and M.E.M. Molitch High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data Am J Med Sci 339 2010 401 410
38. B.J. Powers, M.K. Olsen, and V.A. Smith Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med 154 2011 781 788
39. M. Hoshiga, K. Arishiro, and T. Nakakoji Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease J Atheroscler Thromb 17 2010 705 711
40. C. Baigent, M.J. Landray, and C. Reith The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 2011 [in press: published online June 9 2011]
41. J. Kendrick, M.G. Shlipak, and G. Targher Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study Am J Kidney Dis 55 2010 42 49
42. M.R. Weir, D. Zappe, and L.A. Orloski How early should blood pressure control be achieved for optimal cardiovascular outcomes? J Hum Hypertens 25 2010 211 217
43. A. Patel, S. MacMahon, and J. Chalmers Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 2007 829 840 (Pubitemid 47362321)
44. M.R. Weir, F. Yeh, and A. Silverman Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial J Clin Hypertens 11 2009 540 548
45. W.C. Cushman, G.W. Evans, and R.P. Byington Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
46. R.M.P. Cooper-DeHoff, Y.P. Gong, and E.M.P. Handberg Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease JAMA 304 2010 61 68
47. K.K. Koh, M.J. Quon, and S.H. Han Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes Hypertension 45 2005 1088 1093 (Pubitemid 40770310)
48. A. Ceriello, R. Assaloni, and R. Da Ros Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients Circulation 111 2005 2518 2524 (Pubitemid 40696141)
49. R.E. Schmieder, C. Delles, and A. Mimran Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes Diabetes Care 30 2007 1351
50. M. Ritt, C. Ott, and U. Raff Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus Am J Kidney Dis 53 2009 281 289
51. F.A. Holtkamp, D. de Zeeuw, and P.A. de Graeff Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials Eur Heart J 32 2011 1493 1499